← back to search

Wenyan Li

Fudan University · CN
Area of research
Sensory Systems · Cognitive Neuroscience
Research interest
Research interests include Hearing, Cochlea, Tinnitus, Genetics, Hearing Loss and Rehabilitation, Vestibular and auditory disorders, and Ear Surgery and Otitis Media.
h-index
45
citations
8,467
works
343
NIH funding
primary concept
email

Recent publications

Pou4f3 Deficiency Obstructs the Subtype Differentiation of Vestibular Hair Cells.
2026cited by 1position: contributordoi
Restoring Iron Homeostasis via Smoothened Inhibition: A Novel Strategy Against Hearing Loss.
2026cited by 0position: contributordoi
Balloon Dilation With Tympanostomy Enhances Outcomes in Adult Chronic Otitis Media With Effusion.
2026cited by 0position: contributordoi
Vestibular Assessment and Compensation in Unilateral Acute Vestibular Dysfunction: A Prospective Single-Armed Cohort Study of Vestibular Schwannoma After Surgery.
2026cited by 0position: contributordoi
Targeting Phospholipid Metabolism as an Effective Hearing Protection Strategy.
2026cited by 0position: contributordoi
PKM2 controls cochlear development through lactate-dependent transcriptional regulation.
2025cited by 10position: contributordoi
A biomarker framework for auditory system aging: the Aging Biomarker Consortium consensus statement
Life Medicine 2025cited by 8position: middledoi
Ancient genomes illuminate the origins and dynamic history of East Asian cattle
Science 2025cited by 5position: middledoi
Single-nucleus profiling of mouse inner ear aging uncovers cell type heterogeneity and hair cell subtype-specific age-related signatures.
2025cited by 5position: contributordoi
SnRK2.5-mediated phosphorylation of PIN2 links osmotic stress signaling to auxin-dependent root adaptive growth in Arabidopsis
Molecular Plant 2025cited by 3position: middledoi
A novel proteomics workflow for simultaneous analysis of protein phosphorylation and S-nitrosylation
aBIOTECH 2025cited by 2position: middledoi
A biomarker framework for auditory system aging: the Aging Biomarker Consortium consensus statement.
2025cited by 2position: contributordoi
The role of audiological features and horizontal semicircular canal function at various frequencies in vestibular migraine and Menière’s disease
Acta Oto-Laryngologica 2025cited by 0position: lastdoi
Cross-sectional and longitudinal associations of circulating bile acids and dementia: a systematic review.
2025cited by 0position: contributordoi
The role of audiological features and horizontal semicircular canal function at various frequencies in vestibular migraine and Menière's disease.
2025cited by 0position: contributordoi
Inner ear organoids: Recent progress and potential applications.
2025cited by 0position: contributordoi
Providing Insight for Pediatric Ear Surgery: Analysis of Middle Ear Development via HRCT.
2025cited by 0position: contributordoi
Unraveling the neuroprotective potential of scalp electroacupuncture in ischemic stroke: A key role for electrical stimulation
Neuroscience 2024cited by 12position: middledoi
Nuciferine Protects Cochlear Hair Cells from Ferroptosis through Inhibiting NCOA4-Mediated Ferritinophagy.
2024cited by 10position: contributordoi
Integration of Functional Human Auditory Neural Circuits Based on a 3D Carbon Nanotube System
Advanced Science 2024cited by 9position: lastdoi
Drug screening identifies aldose reductase as a novel target for treating cisplatin-induced hearing loss.
2024cited by 7position: contributordoi
Integration of Functional Human Auditory Neural Circuits Based on a 3D Carbon Nanotube System.
2024cited by 6position: contributordoi
Effects of Polyphenols in Different Teas on Physicochemical Characteristics of Egg White Protein Gel During Tea Eggs Making
Food Biophysics 2024cited by 5position: firstdoi
Comparing Sleep Patterns and Clinical Features between Preschool and School-Age Children with OSA.
2024cited by 4position: contributordoi
Lycocasine A, a Lycopodium Alkaloid from Lycopodiastrum casuarinoides and Its Acid-Sensing Ion Channel 1a Inhibitory Activity
Molecules 2024cited by 3position: middledoi
Clinical practice guidelines for gene therapy to treat hereditary hearing loss
Interdisciplinary medicine 2024cited by 3position: middledoi
The long-term efficacy and safety of balloon dilation eustachian tuboplasty combined with tympanostomy tube insertion for patients with otitis media with effusion: study protocol for a prospective randomized controlled trial.
2024cited by 3position: contributordoi
Cochlear implant/MXene-based electroacoustic stimulation modulates the growth and maturation of spiral ganglion neurons
Engineered Regeneration 2024cited by 2position: middledoi
Novel heterozygous USH1C mutation impacts hair cell mechanotransduction and causes progressive hearing loss.
2024cited by 2position: contributordoi
Corrigendum to "Drug screening identifies aldose reductase as a novel target for treating cisplatin-induced hearing loss" [Free Radic. Biol. Med. 210 (2024) 430-447].
2024cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Renjie Chai · Fudan University15 papers (2014–2024)Yongtao Li · Fudan University12 papers (2016–2022) · 12 papers (2020–2026)Yulong Zhang · University of Iowa10 papers (2016–2023)Yan Chen · Fudan University9 papers (2016–2023)Huawei Li · Fudan University8 papers (2014–2022)Shan Sun · Fudan University8 papers (2014–2022)Jinding Liu · Shanxi Medical University6 papers (2019–2022)Gengqian Zhang · Shanxi Medical University6 papers (2019–2022)Jinjin Wang · Shandong University6 papers (2018–2022)Huawei Li · Shihezi University5 papers (2016–2021)Zidong Liu · Shanxi Medical University5 papers (2019–2021)Jie Shi · Zhejiang Normal University5 papers (2019–2021)Luo Guo · Fudan University5 papers (2016–2022)Huawei Li · Allen Institute for Brain Science4 papers (2018–2025)Xiaojuan Cheng · Kunming University of Science and Technology4 papers (2020–2021)Ting Hao · Shanxi Medical University4 papers (2020–2021)Wenli Ni · Fudan University4 papers (2016–2023)Dan You · Fudan University4 papers (2018–2023)Zeqin Li · Sun Yat-sen University Cancer Center4 papers (2019–2022)